Renal sympathetic denervation: the jury is still out.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?Journal of clinical hypertension (Greenwich, Conn.) · 2018
   Article
2. Short-term safety and efficiency of cryoablation for renal sympathetic denervation in a swine model.Chinese medical journal · 2015
   Article
3. Non-interventional management of resistant hypertension.World journal of cardiology · 2014
   Review
4. Con: renal denervation for all resistant hypertensive patients: the Emperor's new clothes.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2014
   Article
5. Renal nerve ablation for resistant hypertension: the dust has not yet settled.Journal of clinical hypertension (Greenwich, Conn.) · 2014
   Article
6. Renal denervation as an option for the management of hypertension.Journal of biomedical research · 2014
   Review
7. Renal sympathetic denervation: applications in hypertension and beyond.Nature reviews. Cardiology · 2013
   Review
8. Investing in high blood pressure research: a national institutes of health perspective.Hypertension (Dallas, Tex. : 1979) · 2013
   Review
9. Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.Current hypertension reports · 2012
   Review
10. Can catheter-based renal denervation be used safely and effectively to substantially reduce blood pressure in treatment-resistant hypertensive patients?Current cardiology reports · 2011
    Article
11. Sympatho-renal axis in chronic disease.Clinical research in cardiology : official journal of the German Cardiac Society · 2011
    Article
12. Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.European heart journal · 2011
    Review
13. Drug-resistant hypertension: is renal sympathetic denervation the answer?Current cardiology reports · 2011
    Article
14. Renal denervation and blood pressure reduction in resistant hypertension: a systematic review and meta-analysis.Open heart
    Article

Corrections and comments

• Comment on
  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.2010

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as